AAMRI e-news | September 2022

AAMRI e-news | September 2022

19th September, 2022

SUBSCRIBE HERE

In this issue

  1. AAMRI news – AAMRI Convention – program available!
  2. Government update –  Consultations currently open
  3. Sector news – Congratulations Prof Sharon Lewin AO
  4. NHMRC update – NHMRC Corporate Plan available
  5. MRFF update – Grant Assessment Committee members
  6. Funding and award opportunities – EMCR opportunities
  7. Reports and resources – CSIRO Pandemic Preparedness Report
  8. Events and courses –  2022 ACTA Annual Scientific Meeting

Do you have something that you would like featured in a future newsletter? Send it through to communications@aamri.org.au

1. AAMRI news

2022 AAMRI Convention – program now available!

The draft program is now available for our Annual Convention and Dinner. We have a range of international and local speakers, making up a variety of presentations, panels and discussions. View the draft program online, which we’ll be updating as we get closer to the date.

The AAMRI Convention will feature two days of sessions focusing on policy and operational issues important for the medical research institute sector. To be held on Nov 29-30, the venue this year will be QT Hotel, Canberra.

Op Ed: Lift the pace of gender equity in NHMRC grants program

Last month AAMRI President, Professor Kathryn North AC, penned an Opinion Editorial published in The Australian challenging the gender imbalance in NHMRC grants funding. You can read the article in full on our website.

2.  Government update

Independent review into the ARC – update

The review is to be led by Queensland University of Technology Vice-Chancellor Professor Margaret Sheil, and will report to the Minister by March next year.

The Minister has also issued a new Letter of Expectations to the ARC CEO, Ms Judi Zielke PSM. It asks the CEO to develop a new National Interest Test that better aligns with the objectives of different programs and seeks a streamlining of ARC grant applications. The ARC has welcomed the new direction.

Consultations

Guideline for assessing and managing cardiovascular disease (CVD) risk reduction
The new Guideline will provide recommendations and advice for assessing and managing CVD risk for the primary prevention of CVD in Australia. When finalised, it will replace the Absolute CVD risk management guidelines (2012). Closes 28 Sept 2022.

List of critical technologies in the national interest: 2022 update

The Department of Industry, Science and Resources is consulting on the list of current and emerging technologies that are critical for Australia today or could become critical within the next 10 years. The consultation paper is available now. Closes 30 Sept 2022.

South Australian Health and Medical Research Strategy stakeholder engagement

The Discussion Paper: Developing a South Australian Health and Medical Research Strategy has been drafted to guide conversations. Responses are to be emailed by 1 Nov 2022 to Health.StrategyAndIntergovernmentRelations@sa.gov.au.

Inquiry into Long COVID and Repeated COVID Infections

The Committee wants to draw upon the experience and insights of healthcare service providers supporting patients with long COVID and/or repeated COVID infections, to better understand the impacts on Australia’s overall health system. Closes 18 Nov 2022.

3.  Sector news

Cumming Global Centre for Pandemic Therapeutics announced

$250 million has been donated by Mr Geoffrey Cumming for the Cumming Global Centre for Pandemic Therapeutics. The Victorian Government have initially committed $75 million to the Centre. The Centre will be established in the new $650 million Australian Institute for Infectious Disease, a partnership between the University of Melbourne, the Doherty Institute, the Burnet Institute, and the Victorian Government.

Professor Sharon Lewin AO FAH awarded AAHMS Outstanding Female Researcher Medal

Congratulations to Professor Lewin, who has been recognised by the Australian Academy of Health and Medical Sciences (AAHMS) for her body of research and global leadership in the search for a cure to human immunodeficiency virus (HIV), as well as her contribution to the COVID-19 pandemic response.

New Sydney Biomedical Accelerator

The University of Sydney recently announced its largest ever capital investment, a landmark $478 million to build a nation-leading biomedical precinct to fast track research and patient care in New South Wales.

New HealthTech and BioTech venture capital based in WA

The launch of a $250 million Perth-based venture capital fund, Tenmile, will target start-ups in the medical technology to bridge the so-called ‘valley of death’, the period when no revenue is being generated and the companies are still bringing their products to market.

Funding awarded:

Appointments and departures:

In the spotlight: Raising dementia awareness in multicultural communities

“Moving Pictures” is an initiative by the National Ageing Research Institute (NARI). The project provides non-English speaking communities with information and resources about dementia, and supports dementia and aged care services in becoming more inclusive towards culturally and linguistically diverse communities.

4. NHMRC update

NHMRC Corporate Plan 2022–23

The Plan presents the NHMRC’s national strategy for health and medical research aligned with their three strategic purposes of investment, translation and integrity.

NHMRC Research Translation Symposium 2022  – 17-22 Nov 2022

The theme this year is ‘Embracing Diversity’, and the intention is to encourage the translation of research that improves equity and respects the health and health care decision making needs of people of different cultures, ethnic groups, socio-economic groups, abilities or ages.

NHMRC Biennial Awards – Closes 28 Oct 2022.

Is COVID impacting your NHMRC/MRFF funded research?

The NHMRC and the MRFF have put in place measures to help assist researchers whose research has been affected by the COVID-19 pandemic. Further information is available on the NHMRC website or in the latest MRFF newsletter.

5.  MRFF update

Become a MRFF Grant Assessment Committee member

Decisions on which projects should receive MRFF grant funding are based on the assessments of independent Grant Assessment Committees, comprising national and international assessors who consider applications against technical and non-technical assessment criteria, with a strong focus on impact and value.

Subscribe to the MRFF newsletter

To stay updated about MRFF-related changes, you can review the previous editions of the MRFF newsletter and subscribe to their email list.

6.  Funding and award opportunities

CSIRO’s ON Accelerate Program

ON Accelerate is a structured accelerator program for research teams to validate and develop high potential innovative ventures. Applicants need to register their interest before 23 September and you will have until Friday 7 October 2022 to finalise and submit your application.

2023 MND Research Australia – Daniel McLoone $1 million Major Research Initiative (2023-26), closes 29 Sept 2022.

ARCS Australia GROW program for Clinical Research Associates, closes 30 Sept 2022 (NSW).

MTP Connect – round 2 of the Clinical Translation and Commercialisation MedTech program, closes 07 Oct 2022.

2022 Advance Queensland Industry Research Fellowships, available for EMCRs, closes 17 Oct 2022.

Emerging Industry Infrastructure Fund Round 2, up to $6 million to support Synthetic Biology and Biomanufacturing specific infrastructure, facilities, equipment and platforms, closes 20 Oct 2022.

ARC Mid-Career Industry Fellowship, closes 20 Oct 2022.

MRFF 2022 Multiple Sclerosis Research grant opportunity, streams 3 and 4. Minimum data due 16 Nov 2022, closes 30 Nov 2022.

MRFF 2022 Pancreatic Cancer Research grant opportunity, stream 2. Minimum data due 23 Nov 2022, closes 7 Dec 2022.

Register with GrantConnect to receive notifications when new opportunities open.

7.  Reports and resources

CSIRO Pandemic Preparedness Report

CSIRO has identified the most likely sources of future pandemics and how we can be better prepared. It has identified six areas of science and technology critical to our response and made 20 recommendations.

8.  Events and courses

Events

Inaugural Translate 2022 conference – 6-7 Oct, QLD

The conference will bring together biomedical researchers, clinicians and the MedTech and clinical trial industries to form new connections and forge new pathways into the clinic.

AAHMS Annual Meeting – 13-14 October – VIC

The Academy’s flagship annual event is back in an in-person format for the first time in three years.

2022 ACTA Annual Scientific Meeting – 7-8 Nov, SA

The Australian Clinical Trials Alliance (ACTA) is holding the 2022 ACTA Annual Scientific Meeting, including the Australian Registry Annual Scientific Meeting, in-person from 7 – 8 November at SAHMRI in Adelaide. Registrations and abstract submission for the Australian Registry ASM are both open.

Courses

Melbourne MicroCert Drug Commercialisation Fundamentals

This University of Melbourne accredited program co-designed with VCCC Alliance gives attendees access to leading industry experts who provide evidence-based insights and indispensable guidance on the drug development process.  This 6 week program starts 10 Oct 2022. Fee: $990.